C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Clinical and laboratory correlations of low C1 and C4 levels previously found to be a characteristic feature of chronic lymphocytic leukaemia (CLL) were analysed. Abnormalities of C4 were restricted to stage 1, 2 and 3 of CLL, whereas in the more advanced disease (stage 4) only low C1 levels were found. It was demonstrated that the observed disorders were associated with an increased susceptibility of the patients for infections and impair the immune complex precipitation inhibiting capacity of the patients' sera as well.

Original languageEnglish
Pages (from-to)255-259
Number of pages5
JournalImmunology Letters
Volume14
Issue number3
DOIs
Publication statusPublished - 1987

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Antigen-Antibody Complex
Immunoprecipitation
Infection
Serum

Keywords

  • C1
  • C4
  • Chronic lymphocytic leukemia
  • Complement
  • Immune complex

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance. / Füst, G.; Miszlay, Zs; Czink, E.; Varga, L.; Pálóczi, K.; Szegedi, G.; Hollán, S.

In: Immunology Letters, Vol. 14, No. 3, 1987, p. 255-259.

Research output: Contribution to journalArticle

@article{88f47b3a9d0f428c937420b6b977cf93,
title = "C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance",
abstract = "Clinical and laboratory correlations of low C1 and C4 levels previously found to be a characteristic feature of chronic lymphocytic leukaemia (CLL) were analysed. Abnormalities of C4 were restricted to stage 1, 2 and 3 of CLL, whereas in the more advanced disease (stage 4) only low C1 levels were found. It was demonstrated that the observed disorders were associated with an increased susceptibility of the patients for infections and impair the immune complex precipitation inhibiting capacity of the patients' sera as well.",
keywords = "C1, C4, Chronic lymphocytic leukemia, Complement, Immune complex",
author = "G. F{\"u}st and Zs Miszlay and E. Czink and L. Varga and K. P{\'a}l{\'o}czi and G. Szegedi and S. Holl{\'a}n",
year = "1987",
doi = "10.1016/0165-2478(87)90110-6",
language = "English",
volume = "14",
pages = "255--259",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance

AU - Füst, G.

AU - Miszlay, Zs

AU - Czink, E.

AU - Varga, L.

AU - Pálóczi, K.

AU - Szegedi, G.

AU - Hollán, S.

PY - 1987

Y1 - 1987

N2 - Clinical and laboratory correlations of low C1 and C4 levels previously found to be a characteristic feature of chronic lymphocytic leukaemia (CLL) were analysed. Abnormalities of C4 were restricted to stage 1, 2 and 3 of CLL, whereas in the more advanced disease (stage 4) only low C1 levels were found. It was demonstrated that the observed disorders were associated with an increased susceptibility of the patients for infections and impair the immune complex precipitation inhibiting capacity of the patients' sera as well.

AB - Clinical and laboratory correlations of low C1 and C4 levels previously found to be a characteristic feature of chronic lymphocytic leukaemia (CLL) were analysed. Abnormalities of C4 were restricted to stage 1, 2 and 3 of CLL, whereas in the more advanced disease (stage 4) only low C1 levels were found. It was demonstrated that the observed disorders were associated with an increased susceptibility of the patients for infections and impair the immune complex precipitation inhibiting capacity of the patients' sera as well.

KW - C1

KW - C4

KW - Chronic lymphocytic leukemia

KW - Complement

KW - Immune complex

UR - http://www.scopus.com/inward/record.url?scp=0023158833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023158833&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(87)90110-6

DO - 10.1016/0165-2478(87)90110-6

M3 - Article

VL - 14

SP - 255

EP - 259

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 3

ER -